Blomma, a project management and recruitment platform for the end-to-end execution of clinical trials, has secured $5.0M in Seed funding from Felicis Ventures. The investment comes at a peculiar juncture for the company, as its platform has been mothballed due to recent student loan policy changes.
The platform was conceived as a one-stop shop, designed to guide research coordinators through every step of the clinical trials process, from direct-to-participant advertising and trial-matching to managing data streams and sponsor reporting.















